Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have received an average recommendation of “Hold” from the six analysts that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, one has assigned a buy recommendation and one has given a strong buy recommendation to the company.
SAUHY has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft upgraded shares of Straumann from a “hold” rating to a “buy” rating in a research report on Friday, October 31st. Citigroup reaffirmed a “sell” rating on shares of Straumann in a report on Wednesday, January 14th. Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. Finally, UBS Group raised Straumann from a “sell” rating to a “neutral” rating in a report on Tuesday, November 4th.
Read Our Latest Stock Report on Straumann
Straumann Price Performance
Straumann Company Profile
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Read More
- Five stocks we like better than Straumann
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
